BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 33721295)

  • 21. The demise of preimplantation genetic testing for aneuploidy (PGT-A) in Hungary and its effect on patient care.
    Varga K; Tóth N; Bogár ÉB; Csontos L; Szabó K; Debreceni D; Margittai É; Csenki M; Vereczkey A
    Eur J Med Genet; 2019 Aug; 62(8):103669. PubMed ID: 31082515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of IVF live birth outcomes with and without preimplantation genetic testing for aneuploidy (PGT-A): UK Human Fertilisation and Embryology Authority data collection 2016-2018.
    Sanders KD; Silvestri G; Gordon T; Griffin DK
    J Assist Reprod Genet; 2021 Dec; 38(12):3277-3285. PubMed ID: 34766235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of embryo aneuploidy and sperm DNA damage in unexplained recurrent implantation failure patients under NGS-based PGT-A cycles.
    Ping P; Liu Y; Zheng Z; Ma Y; Dong F; Chen X
    Arch Gynecol Obstet; 2023 Sep; 308(3):997-1005. PubMed ID: 37341853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Why do euploid embryos miscarry? A case-control study comparing the rate of aneuploidy within presumed euploid embryos that resulted in miscarriage or live birth using next-generation sequencing.
    Maxwell SM; Colls P; Hodes-Wertz B; McCulloh DH; McCaffrey C; Wells D; Munné S; Grifo JA
    Fertil Steril; 2016 Nov; 106(6):1414-1419.e5. PubMed ID: 27692437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of the male factor on the clinical outcome of intracytoplasmic sperm injection combined with preimplantation aneuploidy testing: observational longitudinal cohort study of 1,219 consecutive cycles.
    Mazzilli R; Cimadomo D; Vaiarelli A; Capalbo A; Dovere L; Alviggi E; Dusi L; Foresta C; Lombardo F; Lenzi A; Tournaye H; Alviggi C; Rienzi L; Ubaldi FM
    Fertil Steril; 2017 Dec; 108(6):961-972.e3. PubMed ID: 28985908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Worldwide live births following the transfer of chromosomally "Abnormal" embryos after PGT/A: results of a worldwide web-based survey.
    Patrizio P; Shoham G; Shoham Z; Leong M; Barad DH; Gleicher N
    J Assist Reprod Genet; 2019 Aug; 36(8):1599-1607. PubMed ID: 31236830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preimplantation genetic testing for aneuploidy helps to achieve a live birth with fewer transfer cycles for the blastocyst FET patients with unexplained recurrent implantation failure.
    Wang S; Liu L; Ma M; Wang H; Han Y; Guo X; Yeung WSB; Cheng Y; Zhang H; Dong F; Zhang B; Tian Y; Song J; Peng H; Yao Y
    Arch Gynecol Obstet; 2023 Aug; 308(2):599-610. PubMed ID: 37246978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perceptions, motivations and decision regret surrounding preimplantation genetic testing for aneuploidy.
    Kaing A; Rosen MP; Quinn MM
    Hum Reprod; 2020 Sep; 35(9):2047-2057. PubMed ID: 32756971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Female obesity increases the risk of miscarriage of euploid embryos.
    Cozzolino M; García-Velasco JA; Meseguer M; Pellicer A; Bellver J
    Fertil Steril; 2021 Jun; 115(6):1495-1502. PubMed ID: 33267960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of preimplantation genetic testing for aneuploidy in a good prognosis IVF population across different age groups.
    Sarkar P; Jindal S; New EP; Sprague RG; Tanner J; Imudia AN
    Syst Biol Reprod Med; 2021 Oct; 67(5):366-373. PubMed ID: 34355997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The age-related required number of zygotes estimated from prior clinical studies of preimplantation genetic testing for aneuploidy (PGT-A).
    Mariya T; Sugimoto T; Kato T; Endo T; Kurahashi H
    Syst Biol Reprod Med; 2023 Feb; 69(1):50-56. PubMed ID: 36624976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Limits imposed by the experimental design of a large prospective non-inferiority study on PGT-A invalidate many of the conclusions.
    Scott RT; de Ziegler D; Pirtea P; Jalas C
    Hum Reprod; 2022 Nov; 37(12):2735-2742. PubMed ID: 36287636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth hormone supplementation ameliorates blastocyst euploidy rates and improves pregnancy outcomes in women undergoing preimplantation genetic testing for aneuploidy cycles.
    Guo Q; Liu P; Zhou W; Xia M; Li J; Lu J; Ma JL; Chen ZJ; Yan J
    Front Endocrinol (Lausanne); 2023; 14():1117706. PubMed ID: 36950683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Next-Generation Sequencing (NGS)-Based Preimplantation Genetic Testing for Aneuploidy (PGT-A) of Trophectoderm Biopsy for Recurrent Implantation Failure (RIF) Patients: a Retrospective Study.
    Tong J; Niu Y; Wan A; Zhang T
    Reprod Sci; 2021 Jul; 28(7):1923-1929. PubMed ID: 33709375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical outcomes of Preimplantation genetic testing (PGT) application in couples with chromosomal inversion, a study in the Chinese Han population.
    Shao Y; Li J; Lu J; Li H; Zhu Y; Jiang W; Yan J
    Reprod Biol Endocrinol; 2020 Aug; 18(1):79. PubMed ID: 32758287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Performance of preimplantation genetic testing for aneuploidy in IVF cycles for patients with advanced maternal age, repeat implantation failure, and idiopathic recurrent miscarriage.
    Lee CI; Wu CH; Pai YP; Chang YJ; Chen CI; Lee TH; Lee MS
    Taiwan J Obstet Gynecol; 2019 Mar; 58(2):239-243. PubMed ID: 30910146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of preimplantation genetic testing for aneuploidies (PGT-A) on clinical outcomes in high risk patients.
    Pantou A; Mitrakos A; Kokkali G; Petroutsou K; Tounta G; Lazaros L; Dimopoulos A; Sfakianoudis K; Pantos K; Koutsilieris M; Mavrou A; Kanavakis E; Tzetis M
    J Assist Reprod Genet; 2022 Jun; 39(6):1341-1349. PubMed ID: 35338417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does PGT-A affect cumulative live birth rate?
    Seckin S; Forman EJ
    Curr Opin Obstet Gynecol; 2023 Jun; 35(3):216-223. PubMed ID: 37185353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elucidating the PGT-A paradox: marginalising the detriment relegates the benefit.
    Scriven PN
    J Assist Reprod Genet; 2022 Nov; 39(11):2475-2481. PubMed ID: 36282412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of exogenous gonadotropin dosage on embryo aneuploidy rate and pregnancy outcome in patients of preimplantation genetic test].
    Zhang JN; Wang J; Peng HM; Ma MY; Wang H; Zhao CC; Jiao MY; Li XH; Yao YQ
    Zhonghua Fu Chan Ke Za Zhi; 2020 Apr; 55(4):253-258. PubMed ID: 32375432
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.